Literature DB >> 27162741

Effect of 0.05% topical cyclosporine for the treatment of symptomatic subepithelial infiltrates due to adenoviral keratoconjunctivitis.

Ilkay Kilic Muftuoglu1, Yonca A Akova2, Sirel G Gungor3.   

Abstract

Entities:  

Year:  2016        PMID： 27162741      PMCID： PMC4853364          DOI： 10.18240/ijo.2016.04.26

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN： 2222-3959            Impact factor:   1.779


× No keyword cloud information.
  7 in total

1.  Topical treatment with 1% cyclosporine for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis.

Authors:  Eliya Levinger; Alana Slomovic; Wiwan Sansanayudh; Irit Bahar; Allan R Slomovic
Journal:  Cornea       Date:  2010-06       Impact factor: 2.651

2.  Topical cyclosporine in the management of shield ulcers.

Authors:  Altug Cetinkaya; Yonca Aydin Akova; Dilek Dursun; Aysel Pelit
Journal:  Cornea       Date:  2004-03       Impact factor: 2.651

3.  Cyclosporine A 1% eye drops for the treatment of subepithelial infiltrates after adenoviral keratoconjunctivitis.

Authors:  Bennie H Jeng; Douglas S Holsclaw
Journal:  Cornea       Date:  2011-09       Impact factor: 2.651

4.  Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.

Authors:  J Hillenkamp; T Reinhard; R S Ross; D Böhringer; O Cartsburg; M Roggendorf; E De Clercq; E Godehardt; R Sundmacher
Journal:  Arch Ophthalmol       Date:  2001-10

5.  Corneal histology after epidemic keratoconjunctivitis.

Authors:  O E Lund; F H Stefani
Journal:  Arch Ophthalmol       Date:  1978-11

6.  [Local cyclosporin A in nummuli after keratoconjunctivitis epidemica. A pilot study].

Authors:  T Reinhard; E Godehardt; H G Pfahl; R Sundmacher
Journal:  Ophthalmologe       Date:  2000-11       Impact factor: 1.059

7.  The effects of topical nonsteroidal anti-inflammatory drugs on adenoviral replication.

Authors:  Y J Gordon; T Araullo-Cruz; E G Romanowski
Journal:  Arch Ophthalmol       Date:  1998-07
  7 in total
  3 in total

1.  Clinical efficacy of combined topical 0.05% cyclosporine A and 0.1% sodium hyaluronate in the dry eyes with meibomian gland dysfunction.

Authors:  Ho-Yun Kim; Ji-Eun Lee; Ha-Na Oh; Ju-Whan Song; Sang-Youp Han; Jong-Soo Lee
Journal:  Int J Ophthalmol       Date:  2018-04-18       Impact factor: 1.779

2.  Comparison of the safety and efficacy of topical Tacrolimus (0.03%) versus dexamethasone (0.05%) for subepithelial infiltrates after adenoviral conjunctivitis.

Authors:  Rahul Bhargava; Prachi Kumar
Journal:  Indian J Ophthalmol       Date:  2019-05       Impact factor: 1.848

3.  Pentacam corneal densitometry-guided treatment of adenoviral corneal subepithelial infiltrates: a comparative study between transepithelial phototherapeutic keratectomy and topical tacrolimus.

Authors:  Tarek Roshdy Elhamaky
Journal:  Int Ophthalmol       Date:  2020-08-27       Impact factor: 2.031
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.